Oral lichen planus: Update on etiopathogenesis, diagnosis and treatment

Vito Crincoli, Maria Beatrice Di Bisceglie, Michele Scivetti, Alberta Lucchese, Simona Tecco, Felice Festa

Research output: Contribution to journalArticle

Abstract

Lichen planus is an inflammatory mucocutaneous disorder. Skin, oral and genital mucosal surfaces, scalp, and nails can be affected. Its development is chronic, with a possible malignant degeneration. Spontaneous remission is rare. Although the etiology of oral lichen planus is still unclear, there is evidence that it is a complex immunologic disease mediated by cytotoxic cells directed against basilar keratinocytes and resulting in vacuolar degeneration and lysis of basal cells. In long-standing, atrophic and erosive forms, the treatment is usually aimed at relieving pain and may include immunosuppressive agents, especially corticosteroid, topical cyclosporin, or tacrolimus, topical and systemic retinoids. However, the use of these drugs may be accompanied by several side effects. For this reason clinicians, currently, have focused their attention to new biological agents which provide selective immunological results with less side effects than generic immunosupressants.

Original languageEnglish
Pages (from-to)11-20
Number of pages10
JournalImmunopharmacology and Immunotoxicology
Volume33
Issue number1
DOIs
Publication statusPublished - Mar 2011

Fingerprint

Oral Lichen Planus
Spontaneous Remission
Lichen Planus
Nails
Immune System Diseases
Retinoids
Biological Factors
Tacrolimus
Immunosuppressive Agents
Scalp
Keratinocytes
Cyclosporine
Skin
Adrenal Cortex Hormones
Cells
Pain
Therapeutics
Pharmaceutical Preparations
Lichens

Keywords

  • biologics
  • Lichen planus
  • therapy

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Pharmacology
  • Toxicology

Cite this

Oral lichen planus : Update on etiopathogenesis, diagnosis and treatment. / Crincoli, Vito; Di Bisceglie, Maria Beatrice; Scivetti, Michele; Lucchese, Alberta; Tecco, Simona; Festa, Felice.

In: Immunopharmacology and Immunotoxicology, Vol. 33, No. 1, 03.2011, p. 11-20.

Research output: Contribution to journalArticle

Crincoli, Vito ; Di Bisceglie, Maria Beatrice ; Scivetti, Michele ; Lucchese, Alberta ; Tecco, Simona ; Festa, Felice. / Oral lichen planus : Update on etiopathogenesis, diagnosis and treatment. In: Immunopharmacology and Immunotoxicology. 2011 ; Vol. 33, No. 1. pp. 11-20.
@article{7160ecb2678e48f394e37986aac1c2d2,
title = "Oral lichen planus: Update on etiopathogenesis, diagnosis and treatment",
abstract = "Lichen planus is an inflammatory mucocutaneous disorder. Skin, oral and genital mucosal surfaces, scalp, and nails can be affected. Its development is chronic, with a possible malignant degeneration. Spontaneous remission is rare. Although the etiology of oral lichen planus is still unclear, there is evidence that it is a complex immunologic disease mediated by cytotoxic cells directed against basilar keratinocytes and resulting in vacuolar degeneration and lysis of basal cells. In long-standing, atrophic and erosive forms, the treatment is usually aimed at relieving pain and may include immunosuppressive agents, especially corticosteroid, topical cyclosporin, or tacrolimus, topical and systemic retinoids. However, the use of these drugs may be accompanied by several side effects. For this reason clinicians, currently, have focused their attention to new biological agents which provide selective immunological results with less side effects than generic immunosupressants.",
keywords = "biologics, Lichen planus, therapy",
author = "Vito Crincoli and {Di Bisceglie}, {Maria Beatrice} and Michele Scivetti and Alberta Lucchese and Simona Tecco and Felice Festa",
year = "2011",
month = "3",
doi = "10.3109/08923973.2010.498014",
language = "English",
volume = "33",
pages = "11--20",
journal = "Immunopharmacology and Immunotoxicology",
issn = "0892-3973",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Oral lichen planus

T2 - Update on etiopathogenesis, diagnosis and treatment

AU - Crincoli, Vito

AU - Di Bisceglie, Maria Beatrice

AU - Scivetti, Michele

AU - Lucchese, Alberta

AU - Tecco, Simona

AU - Festa, Felice

PY - 2011/3

Y1 - 2011/3

N2 - Lichen planus is an inflammatory mucocutaneous disorder. Skin, oral and genital mucosal surfaces, scalp, and nails can be affected. Its development is chronic, with a possible malignant degeneration. Spontaneous remission is rare. Although the etiology of oral lichen planus is still unclear, there is evidence that it is a complex immunologic disease mediated by cytotoxic cells directed against basilar keratinocytes and resulting in vacuolar degeneration and lysis of basal cells. In long-standing, atrophic and erosive forms, the treatment is usually aimed at relieving pain and may include immunosuppressive agents, especially corticosteroid, topical cyclosporin, or tacrolimus, topical and systemic retinoids. However, the use of these drugs may be accompanied by several side effects. For this reason clinicians, currently, have focused their attention to new biological agents which provide selective immunological results with less side effects than generic immunosupressants.

AB - Lichen planus is an inflammatory mucocutaneous disorder. Skin, oral and genital mucosal surfaces, scalp, and nails can be affected. Its development is chronic, with a possible malignant degeneration. Spontaneous remission is rare. Although the etiology of oral lichen planus is still unclear, there is evidence that it is a complex immunologic disease mediated by cytotoxic cells directed against basilar keratinocytes and resulting in vacuolar degeneration and lysis of basal cells. In long-standing, atrophic and erosive forms, the treatment is usually aimed at relieving pain and may include immunosuppressive agents, especially corticosteroid, topical cyclosporin, or tacrolimus, topical and systemic retinoids. However, the use of these drugs may be accompanied by several side effects. For this reason clinicians, currently, have focused their attention to new biological agents which provide selective immunological results with less side effects than generic immunosupressants.

KW - biologics

KW - Lichen planus

KW - therapy

UR - http://www.scopus.com/inward/record.url?scp=79551605531&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551605531&partnerID=8YFLogxK

U2 - 10.3109/08923973.2010.498014

DO - 10.3109/08923973.2010.498014

M3 - Article

C2 - 20604639

AN - SCOPUS:79551605531

VL - 33

SP - 11

EP - 20

JO - Immunopharmacology and Immunotoxicology

JF - Immunopharmacology and Immunotoxicology

SN - 0892-3973

IS - 1

ER -